Gastrointestinal Stromal Tumor
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
| Type | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| Sensitivity (+) | PDGFRA p.D842V | Gastrointestinal Stromal Tumor | Avapritinib | FDA |
| Sensitivity (+) | CD117 + | Gastrointestinal Stromal Tumor | Imatinib | FDA |
| Sensitivity (+) | FIP1L1::PDGFRA | Gastrointestinal Stromal Tumor | Imatinib | FDA |
| Sensitivity (+) | HER2-positive | Gastrointestinal Stromal Tumor | Trastuzumab | FDA |
| Sensitivity (+) | CD117 + | Gastrointestinal Stromal Tumor | Imatinib | HC |
| Sensitivity (+) | CD117 + | Gastrointestinal Stromal Tumor | Imatinib | HC |